Literature DB >> 6304041

Amino acid-specific ADP-ribosylation.

J Moss, D A Yost, S J Stanley.   

Abstract

[adenine-U-14C]ADP-ribose-agmatine and [adenine-U-14C ))ADP-ribose-histone were synthesized by an NAD:arginine ADP-ribosyltransferase from [14C]NAD and agmatine and histone, respectively. The pseudo-first order rate constants for breakdown of the two components either in 0.4 N NaOH or in 0.4 M neutral hydroxylamine were identical. Hydroxylamine treatment of [14C]ADP-ribose-agmatine or [32P]ADP-ribose-histone yielded a single radioactive product which was separated by high pressure liquid chromatography and identified as ADP-ribose-hydroxamate by the formation of a ferric chloride complex. Hydrolysis of ADP-ribose-hydroxamate with snake venom phosphodiesterase resulted in the formation of 5'-AMP, consistent with the presence of a pyrophosphate bond. Incubation of ADP-ribose-[14C]agmatine, synthesized by the ADP-ribosyltransferase from NAD and [14C]agmatine, with 0.4 M neutral hydroxylamine resulted in the release of [14C]agmatine rather than phosphoribosyl[14C]agmatine. In addition, neither NAD nor ADP-ribose reacts with hydroxylamine; i.e. there was no evidence of nucleophilic attack by hydroxylamine at the pyrophosphate bond. The ADP-ribosyl-protein linkage formed by the NAD:arginine ADP-ribosyltransferase is considerably more stable to hydroxylamine than is the ADP-ribose-glutamate bond. The presence of ADP-ribose-arginine and ADP-ribose-glutamate synthesized by the ADP-ribosyltransferase and poly(ADP-ribose) synthetase, respectively, may be the chemical basis for the "hydroxylamine-stable" and "hydroxylamine-labile" bonds described by Hilz (Hilz, H. (1981) Hoppe-Seyler's Z. Physiol. Chem. 362, 1415-1425).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304041

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Eukaryotic nuclear ADP-ribosylation reactions.

Authors:  J C Gaal; C K Pearson
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

2.  Site-specific analysis of the Asp- and Glu-ADP-ribosylated proteome by quantitative mass spectrometry.

Authors:  Peng Li; Yuanli Zhen; Yonghao Yu
Journal:  Methods Enzymol       Date:  2019-07-24       Impact factor: 1.600

3.  Site-specific characterization of the Asp- and Glu-ADP-ribosylated proteome.

Authors:  Yajie Zhang; Jianqi Wang; Ming Ding; Yonghao Yu
Journal:  Nat Methods       Date:  2013-08-18       Impact factor: 28.547

Review 4.  Target protein for eucaryotic arginine-specific ADP-ribosyltransferase.

Authors:  M Tsuchiya; M Shimoyama
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

5.  The Promise of Proteomics for the Study of ADP-Ribosylation.

Authors:  Casey M Daniels; Shao-En Ong; Anthony K L Leung
Journal:  Mol Cell       Date:  2015-06-18       Impact factor: 17.970

6.  Nicotinamide Augments the Anti-Inflammatory Properties of Resveratrol through PARP1 Activation.

Authors:  Maria Yanez; Megha Jhanji; Kendall Murphy; R Michael Gower; Mathew Sajish; Ehsan Jabbarzadeh
Journal:  Sci Rep       Date:  2019-07-15       Impact factor: 4.379

7.  Monoclonal Anti-AMP Antibodies Are Sensitive and Valuable Tools for Detecting Patterns of AMPylation.

Authors:  Dorothea Höpfner; Joel Fauser; Marietta S Kaspers; Christian Pett; Christian Hedberg; Aymelt Itzen
Journal:  iScience       Date:  2020-11-13

Review 8.  Are PARPs promiscuous?

Authors:  Karla L H Feijs; Roko Žaja
Journal:  Biosci Rep       Date:  2022-05-27       Impact factor: 3.840

9.  Sex-specific signaling in the blood-brain barrier is required for male courtship in Drosophila.

Authors:  Valbona Hoxha; Chamala Lama; Peter L Chang; Sumit Saurabh; Naiya Patel; Nicole Olate; Brigitte Dauwalder
Journal:  PLoS Genet       Date:  2013-01-24       Impact factor: 5.917

10.  Serine is the major residue for ADP-ribosylation upon DNA damage.

Authors:  Luca Palazzo; Orsolya Leidecker; Evgeniia Prokhorova; Helen Dauben; Ivan Matic; Ivan Ahel
Journal:  Elife       Date:  2018-02-26       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.